U.S. counties where doctors received high volumes of opioid marketing saw more prescriptions and, in turn, more overdose deaths, according to a new study.

The Trump administration and Congress are gearing up for a renewed campaign to bring the companies to heel. Will it work?

The new governor wants to shift the state's Medicaid program to a direct purchase system and allow private businesses to join its buying pool.

Many of the expected January 1 price increases were lower than past hikes, a reflection of ongoing regulatory pressure.

Insys Therapeutics could become the first corporate casualty of the opioid epidemic, collapsing under legal expenses and plummeting sales.

Seth Frotman's Student Borrower Protection Center won't have the enforcement power his former employer, the CFPB, had.

Experts and analysts worry that the next generation of graduates could default on their loans at even higher rates than in the immediate wake of the financial crisis.

While tech jobs pay well across the board, the health-care industry offers the largest paychecks at the very top of the spectrum.